FirstIgnite is supporting the commercialization of Florida International University’s new system for developing brain computer interface (iBCI) technology. This technology offers numerous advantages, including the ability to develop non-invasive iBCI decoders using emulated brain data. Additionally, this technology allows un-implanted humans to interact with machine learning techniques, generating emulated brain data to develop decoders. By using this approach, iBCIs can be designed and tested at a faster rate, as hundreds of operators can test iBCIs for a minimal cost.
The iBCI technology offers a protocol that can be utilized to develop a brain-computer interface or a neural interface for controlling various devices, such as wheelchairs or robotic arms. The global brain computer interface market size was worth $2.13 billion in 2022 and is expected to reach over $9.44 billion by 2032.
Florida International University’s iBCI technology is ready for collaboration (licensing, partnerships, industry feedback, etc.). Is your company the right fit? If you’d be available for a conversation with the Florida International University team, you can schedule a time directly on their team’s calendar here.
